MMP inhibition in prostate cancer

Medicine & Life Sciences

• Tetracyclines 82%
• Matrix Metalloproteinases 58%
• Prostatic Neoplasms 48%
• Doxycycline 40%
• Neoplasm Metastasis 27%
• Matrix Metalloproteinase Inhibitors 21%
• Alendronate 11%
• Paraplegia 10%
• Lung 9%
• Paclitaxel 8%
• Neoplasms 8%
• Pharmaceutical Preparations 7%
• Cell Movement 7%
• Calcium 5%
• Cell Proliferation 5%
• Clinical Trials 5%
• Bone and Bones 5%
• Cell Line 5%
• Growth 4%
• Incidence 4%
• In Vitro Techniques 3%
• Therapeutics 1%

Arts & Humanities

• Prostate Cancer 100%
• Cells 43%
• Rat 20%
• Drugs 12%
• Calcium 11%
• Toxicity 10%
• Clinical Trials 9%
• Secretion 8%
• Metabolism 7%
• Efficacy 7%
• Excess 7%
• Onset 6%
• Invasion 6%

Chemical Compounds

• Doxycycline 87%
• Tetracycline 34%
• Matrix Metalloproteinase Inhibitor 23%
• Drug 16%
• Pharmacological Metabolism 11%
• Calcium(0) 11%